Cipla Limited gets unaudited consolidated financial results for quarter ended September 30th, 2022. Differentiated pipeline unlocking and continued One-India momentum drive core revenue growth of 12 pc and expansion in EBITDA margin.
Revenue growth for the quarter was at 6 pc on a reported basis and a strong 12% on a covid adjusted base of last year; One-India Robust traction in core portfolio across therapies and business segments; 15 pc YoY ex-covid growth.
- Read more about Cipla gets positive financial results for quarter
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2022/cipla-gets-positive-financial-results-for-quarter
No comments:
Post a Comment